A March 2020 paper that set off months of angry debates about whether hydroxychloroquine is effective in treating COVID-19 has “gross methodological shortcomings” that “do not justify the far-reaching conclusions about the efficacy of hydroxychloroquine in Covid-19,” according to a review commissioned by the journal that published the original work.
The comments, by Frits Rosendaal, of Leiden University Medical Center in the Netherlands, came as part of a review commissioned by International Society of Antimicrobial Chemotherapy (ISAC), which publishes the journal along with Elsiever. ISAC had issued a statement about the paper in April, saying it “does not meet the [International Society of Antimicrobial Chemotherapy’s] expected standard.”
The study, Rosendaal writes,
Continue reading French hydroxychloroquine study has “major methodological shortcomings” and is “fully irresponsible,” says review, but is not being retracted